| 2025-11-24 |
详情>>
内部人交易：
Anderson Robert Eugene Jr股份增加8600.00股
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.62美元,归母净利润-7843.4万美元,同比去年增长-2509.65%
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-1.4美元,归母净利润-6762.7万美元,同比去年增长-316.77%
|
| 2025-05-08 |
详情>>
股本变动：
变动后总股本4830.79万股
变动原因 ▼▲
- 原因：
- From December 31, 2024 to March 31, 2025
Issuance of common stock pursuant to exercise of stock options
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.48美元,归母净利润-2340.3万美元,同比去年增长-193.45%
|
| 2025-04-14 |
股东大会：
将于2025-05-23召开股东大会
会议内容 ▼▲
- 1.To re-elect Robert Anderson, Jr. and Michael J. O’Donnell, as Class I Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.To approve an amendment to the Company’s Non-employee Director Compensation Program;
3.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to reduce the Company’s Board classification from three to two;
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025;
5.To approve, by a non-binding advisory vote, 2024 executive compensation for the Company’s named executive officers;
|
| 2025-03-25 |
复牌提示：
2025-03-25 08:00:00 停牌，复牌日期 2025-03-25 08:35:00
|
| 2025-03-03 |
详情>>
业绩披露：
2024年年报每股收益-0.53美元,归母净利润-2434.2万美元,同比去年增长74.96%
|
| 2025-03-03 |
详情>>
业绩披露：
2022年年报每股收益-1.9美元,归母净利润-7624.6万美元,同比去年增长-135.44%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.07美元,归母净利润325.50万美元,同比去年增长104.27%
|
| 2024-11-07 |
财报披露：
美东时间 2024-11-07 盘前发布财报
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益-1.21美元,归母净利润-5064.7万美元,同比去年增长-37.42%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益0.70美元,归母净利润3119.80万美元,同比去年增长161.60%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益0.58美元,归母净利润2504.30万美元,同比去年增长203.18%
|
| 2024-03-26 |
股东大会：
将于2024-05-09召开股东大会
会议内容 ▼▲
- 1.To re-elect Remi Barbier, Sanford R. Robertson and Patrick J. Scannon, M.D., Ph.D. as Class III Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024;
3.To approve, by a non-binding advisory vote, the 2023 executive compensation for the Company’s named executive officers;
4.To transact such other business as may properly be brought before the Annual Meeting and any adjournment(s) or postponement(s) thereof.
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益-2.32美元,归母净利润-9721.7万美元,同比去年增长-27.5%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.82美元,归母净利润-7629.8万美元,同比去年增长-33.59%
|
| 2023-03-27 |
股东大会：
将于2023-05-04召开股东大会
会议内容 ▼▲
- 1.To re-elect Robert Z. Gussin, Ph.D. and Richard J. Barry as Class II Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company;
3.To approve the Company’s Non-employee Director Compensation Program;
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023;
5.To approve, by a non-binding advisory vote, the 2022 executive compensation for the Company’s named executive officers;
6.To hold a non-binding, advisory vote on the frequency of non-binding, advisory votes on the executive compensation for the Company’s named executive officers;
7.To transact such other business as may properly be brought before the Annual Meeting and any adjournment(s) or postponement(s) thereof.
|
| 2022-03-24 |
股东大会：
将于2022-05-05召开股东大会
会议内容 ▼▲
- 1.Proposal One: To re-elect Nadav Friedmann, Ph.D., M.D. and Michael J. O’Donnell as Class I Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.Proposal Two: To approve Amendment No. 1 to the Company’s 2018 Omnibus Incentive Plan, which increases the authorized number of shares issuable thereunder by 4,000,000, from 1,000,000 to 5,000,000 authorized shares;
3.Proposal Three: To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2022;
4.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-31 |
股东大会：
将于2021-05-06召开股东大会
会议内容 ▼▲
- 1.Proposal One: To re-elect Remi Barbier, Sanford R. Robertson and Patrick J. Scannon, M.D., Ph.D. as Class III Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.Proposal Two: To approve Amendment No. 1 to the Company’s 2018 Omnibus Incentive Plan, which increases the authorized number of shares issuable thereunder by 4,000,000, from 1,000,000 to 5,000,000 authorized shares;
3.Proposal Three: To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2021;
4.Proposal Four: To approve, by a non-binding advisory vote, the 2020 executive compensation for the Company’s named executive officers;
5.To transact such other business as may properly be brought before the Annual Meeting and any adjournment(s) thereof.
|
| 2020-03-26 |
股东大会：
将于2020-05-07召开股东大会
会议内容 ▼▲
- 1.To re-elect Robert Z. Gussin, Ph.D. and Saira Ramasastry as Class II Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.To approve the Amendment No. 1 to the Cassava Sciences, Inc. 2018 Omnibus Incentive Plan, which increases the authorized number of shares by 2,000,000, so that a total of 3,000,000 shares are authorized to be granted under the Cassava Sciences, Inc. 2018 Omnibus Incentive Plan, as amended;
3.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2020;
4.To approve, by a non-binding advisory vote, the 2019 executive compensation for the Company’s executive officers;
5.To transact such other business as may properly be brought before the Annual Meeting and any adjournment(s) thereof.
|
| 2019-03-29 |
股东大会：
将于2019-05-09召开股东大会
会议内容 ▼▲
- 1.To re-elect Nadav Friedmann, Ph.D., M.D. and Michael J. O’Donnell as Class I Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2019;
3.To approve, by a non-binding advisory vote, the 2018 executive compensation for the Company’s executive officers;
4.To transact such other business as may properly be brought before the meeting and any adjournment(s) thereof.
|
| 2018-03-27 |
股东大会：
将于2018-05-10召开股东大会
会议内容 ▼▲
- 1.To re-elect Remi Barbier, Sanford R. Robertson and Patrick J. Scannon, M.D., Ph.D. as Class III Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.To approve the 2018 Omnibus Incentive Plan and the reservation of a total of 1,000,000 shares of our common stock for issuance thereunder;
3.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2018;
4.To approve, by a non-binding advisory vote, the 2017 executive compensation for the Company’s executive officers;
5.To transact such other business as may properly be brought before the meeting and any adjournment(s) thereof.
|
| 2017-05-08 |
详情>>
拆分方案：
每7.0000合并分成1.0000股
|
| 2017-03-29 |
股东大会：
将于2017-05-04召开股东大会
会议内容 ▼▲
- 1.To elect Robert Z. Gussin, Ph.D. and Saira Ramasastry as Class II Directors to serve for three-year terms and until their successors are duly elected and qualified (Proposal One);
2.To approve of the amendment to the Company’s Restated Certificate of Incorporation to effect, at the discretion of the Company’s Board of Directors, up to a ten-to-one reverse stock split of the outstanding shares of our common stock (Proposal Two);
3.To approve the 2017 Omnibus Incentive Plan, including for purposes of Section 162(m)(4)(C) of the Internal Revenue Code of 1986, as amended, and the reservation of a total of 7,000,000 shares of our common stock for issuance thereunder (Proposal Three);
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2017 (Proposal Four);
5.To approve, by a non-binding advisory vote, the 2016 executive compensation for the Company’s executive officers (Proposal Five);
6.To hold a non-binding, advisory vote on the frequency of non-binding, advisory votes on executive compensation (Proposal Six);
7.To transact such other business as may properly be brought before the meeting and any adjournment(s) thereof.
|
| 2016-04-14 |
股东大会：
将于2016-05-12召开股东大会
会议内容 ▼▲
- 1.To elect Nadav Friedmann, Ph.D., M.D. and Michael J. O’Donnell as Class I Directors to serve for three-year terms and until their successors are duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2016;
3.To approve, by a non-binding advisory vote, the 2015 executive compensation for the Company’s executive officers;
4.To transact such other business as may properly be brought before the meeting and any adjournment(s) thereof.
|
| 2012-12-07 |
除权日：
美东时间 2012-12-13 每股派息0.75美元
|
| 2010-10-25 |
除权日：
美东时间 2010-12-13 每股派息2.00美元
|